Whilst we worry about starting treatment for the first time, there are plenty of treatment choices potentially available to us. However, for those navigating treatment for relapsed disease the picture is often more complex and with less options available.
On 6 December 2022, CLLAN (CLL Advocates Network) hosted a webinar on “CLL treatment in the relapsed-refractory setting and promising therapeutic approaches to fulfil unmet needs”.
This educational session discussed advances in how relapsed/refractory CLL patients and those who fail a treatment are treated today. What therapies are used for subsequent treatments and what promising new developments may fulfil unmet treatment needs?
Here's the link -
clladvocates.net/cllan-webi...
Jackie